{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-22",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Completed",
      "city": "Irving",
      "state": "TX",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "94868",
      "recalling_firm": "Medisca Inc.",
      "address_1": "6641 N Belt Line Rd Ste 130",
      "address_2": "N/A",
      "postal_code": "75063-6001",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide in the USA and Canada",
      "recall_number": "D-0570-2024",
      "product_description": "Budesonide, USP (Micronized), 500 mg, White to off-white odorless, crystalline powder, Medisca Inc., Plattsburgh, NY, 12901, USA, NDC: 38779-3097-00.",
      "product_quantity": "113 bottles",
      "reason_for_recall": "CGMP Deviations and Presence of Particulate Matter: Glass",
      "recall_initiation_date": "20240626",
      "center_classification_date": "20240628",
      "report_date": "20240710",
      "code_info": "Lot #s: 202323/G, 202323/H, Exp. 07/31/2026"
    }
  ]
}